Misplaced Pages

Prothionamide: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 19:13, 1 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit Revision as of 19:24, 1 September 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to watched fields - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_PhaNext edit →
Line 1: Line 1:
{{Drugbox {{Drugbox
| Watchedfields = changed
| verifiedrevid = 444070509 | verifiedrevid = 444070509
| IUPAC_name = 2-propylpyridine-4-carbothioamide | IUPAC_name = 2-propylpyridine-4-carbothioamide

Revision as of 19:24, 1 September 2011

Pharmaceutical compound
Prothionamide
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
IUPAC name
  • 2-propylpyridine-4-carbothioamide
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.034.615 Edit this at Wikidata
Chemical and physical data
FormulaC9H12N2S
Molar mass180.271 g/mol g·mol
  (verify)

Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.

It has also been tested for use in the treatment of leprosy.

See also

References

  1. Wang F, Langley R, Gulten G; et al. (2007). "Mechanism of thioamide drug action against tuberculosis and leprosy". J. Exp. Med. 204 (1): 73–8. doi:10.1084/jem.20062100. PMC 2118422. PMID 17227913. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  2. Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH (2006). "A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy". Am. J. Trop. Med. Hyg. 74 (3): 457–61. PMID 16525107. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)


Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04)
Nucleic acid inhibitor
Rifamycins/
RNA polymerase inhibitor
Antifolates/DSI
ASA
Topoisomerase inhibitors/
quinolones
Protein synthesis inhibitor
Aminoglycosides
Oxazolidone
Polypeptide antibiotics
Cell envelope antibiotic
Peptidoglycan layer
Arabinogalactan layer
Mycolic acid layer
Other/unknown
Combinations


Stub icon

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Categories: